Sandoz GmbH - Business Unit Technological Development and Manufacturing of Biological Medicinal Products Schaftlach (BTDM DPS) (manufacturer responsible for batch release)

The drug is used to treat non-Hodgkin lymphomas (specifically follicular and diffuse large B-cell lymphoma), chronic lymphocytic leukemia, granulomatosis with polyangiitis, microscopic polyangiitis, pemphigus vulgaris, and severe rheumatoid arthritis.

Dosage form: concentrate for infusion solution

ATC: L01FA01